RNS60

· Revalesio Corporation

Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for RNS60, covering 2011-10-04 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis [Phase 2]